Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Industry urges restraint at 510(k) modifications meeting. User fee sequestration unaddressed at House Appropriations Committee markup. More news


Related Content

Ophthalmic Devices Panel Supports Safety For Ocular Therapeutix’ ReSure Sealant, But Other Votes Mixed
People Briefs: Uroplasty, PCORI, TeraRecon, Pocared Diagnostics
Industry Says Update To 510(k) Modification Policy Should Emphasize Design Controls, Risk Management
New Products In Brief
House Plan Includes No Increase For CDRH In 2014; User Fee Sequester Unresolved
FDA Subject To More Oversight Following User Fee Bill Passage
CDRH Plans To Redraft Maligned 510(k) Modifications Proposal


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts